98%
921
2 minutes
20
Mycobacterium abscessus is an emerging pathogen that causes chronic pulmonary infection. Treatment is challenging owing in part to our incomplete understanding of M. abscessus virulence mechanisms that enable pathogen persistence, such as the differing pathogenicity of M. abscessus smooth (S) and rough (R) colony morphotype. While R M. abscessus is associated with chronic infection and worse patient outcomes, it is unknown how immune responses to S and R M. abscessus differ in an acute pulmonary infection setting. In this study, immunological outcomes of M. abscessus infection with S and R morphotypes were examined in an immune-competent C3HeB/FeJ murine model. R M. abscessus infection was associated with the rapid production of inflammatory chemokines and recruitment of activated, MHC-II Ly6C macrophages to lungs and mediastinal LN (mLN). While both S and R M. abscessus increased T helper 1 (Th1) phenotype T cells in the lung, this was markedly delayed in mice infected with S M. abscessus. However, histopathological involvement and bacterial clearance were similar regardless of colony morphotype. These results demonstrate the importance of M. abscessus colony morphotype in shaping the development of pulmonary immune responses to M. abscessus, which further informs our understanding of M. abscessus host-pathogen interactions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/eji.202350610 | DOI Listing |
J Genet Eng Biotechnol
September 2025
Department of Biology, College of Science, University of Hail, P.O. Box 2440, Ha'il 2440, Saudi Arabia; Medical and Diagnostic Research Centre, University of Ha'il, Hail 55473, Saudi Arabia. Electronic address:
Staphylococcus aureus is known as a significant contributor to a variety of severe, life-threatening illnesses. Infectious diseases associated with biofilm-producing S. aureus can lead to a substantial increase in morbidity and mortality rates.
View Article and Find Full Text PDFBMC Microbiol
August 2025
Antibiotic Resistance and Phage Therapy Laboratory, Centre for Advanced Research in Bacteriophage and Infectious Diseases, School of Bio Sciences and Technology, Vellore Institute of Technology (VIT), Vellore, 632014, Tamil Nadu, India.
Phage therapy has been explored and used compassionately in the post-antibiotic era, though phage resistance might pose a serious challenge. The advent of hypervirulent and hypermucoviscous traits in Klebsiella pneumoniae limits therapeutic choices. This study investigated the phage resistance in hypermucoviscous hypervirulent Klebsiella pneumoniae clinical strain Kleb_53.
View Article and Find Full Text PDFbioRxiv
July 2025
Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
subspecies () is an emerging environmental pathogen highly adapted to a wide range of niches, from treated water systems to mammalian tissues. On solid media, forms two distinct colony morphologies, smooth transparent (SmT) and smooth opaque (SmO). These colony morphologies are representative of broader differential phenotypic states in which SmT cells are virulent and have high resistance to antibiotics while SmO cells are avirulent, antibiotic-sensitive and grow faster than SmT cells in culture.
View Article and Find Full Text PDFMicrobiol Spectr
September 2025
Department of Epidemiology and Ecology of Antimicrobial Resistance, Helmholtz Institute for One Health, Helmholtz Center for Infection Research HZI, Greifswald, Germany.
, an important opportunistic pathogen, is traditionally classified into classic and hypervirulent pathotypes. Convergent strains combining antimicrobial resistance (AMR) and hypervirulence have emerged globally, posing a significant health challenge. In this study, we investigated potential in-host evolution and morphotypic variation among consecutive ST147 isolates from a single patient.
View Article and Find Full Text PDFIndian J Microbiol
June 2025
Department of Microbiology, Center of Biological Sciences, Paraná State University of Londrina, Londrina, Paraná Brazil.
is an opportunistic yeast pathogen that has the ability to develop resistance to fluconazole. This study evaluated the effect of fluconazole on the rise of phenotypic switching in , an event that affects virulence in this species clinical isolate 49.07 switched reversibly at high frequency (10 to 10) after growth in presence of subinhibitory concentration of fluconazole (0.
View Article and Find Full Text PDF